Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients

Clinical trial NCT05116826 · COMPLETED

Trial details

NCT number: NCT05116826
Sponsor: Genfit
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate Hepatic Impairment Severe Hepatic Impairment Liver Diseases

Start date: 2021-11-05
Primary completion: 2022-04-08
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.